Geneos Wealth Management’s Cytokinetics CYTK Stock Holding History

Geneos Wealth Management’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-17	Closed	-$562	–	2658
2025 Q2	$562	Buy	+17	New	+$591	﹤0.01%	3093
2022 Q3	–	Sell	-500	Closed	-$20K	–	2138
2022 Q2	$20K	Sell	500 -10	-2%	-$403	﹤0.01%	1675
2022 Q1	$18K	Buy	510 +10	+2%	+$355	﹤0.01%	1847
2021 Q4	$22K	Sell	500 -500	-50%	-$19.3K	﹤0.01%	1839
2021 Q3	$36K	Hold	1,000	–	–	﹤0.01%	1645
2021 Q2	$20K	Sell	1,000 -500	-33%	-$11.7K	﹤0.01%	1913
2021 Q1	$38K	Hold	1,500	–	–	﹤0.01%	1768
2020 Q4	$35K	Buy	1,500 +500	+50%	+$9.14K	﹤0.01%	1623
2020 Q3	$23K	Hold	1,000	–	–	﹤0.01%	1591
2020 Q2	$23K	Hold	1,000	–	–	﹤0.01%	1556
2020 Q1	$11K	Hold	1,000	–	–	﹤0.01%	1762
2019 Q4	$10K	Hold	1,000	–	–	﹤0.01%	1959
2019 Q3	$11K	Hold	1,000	–	–	﹤0.01%	1847
2019 Q2	$11K	Hold	1,000	–	–	﹤0.01%	1867
2019 Q1	$8K	Hold	1,000	–	–	﹤0.01%	1895
2018 Q4	$6K	Hold	1,000	–	–	﹤0.01%	1917
2018 Q3	$9K	Hold	1,000	–	–	﹤0.01%	1866
2018 Q2	$8K	Hold	1,000	–	–	﹤0.01%	1780
2018 Q1	$7K	Hold	1,000	–	–	﹤0.01%	1752
2017 Q4	$8K	Hold	1,000	–	–	﹤0.01%	1693
2017 Q3	$14K	Hold	1,000	–	–	﹤0.01%	1449
2017 Q2	$12K	Hold	1,000	–	–	﹤0.01%	1461
2017 Q1	$12K	Hold	1,000	–	–	﹤0.01%	1413
2016 Q4	$12K	Hold	1,000	–	–	﹤0.01%	1375
2016 Q3	$9K	Hold	1,000	–	–	﹤0.01%	1387
2016 Q2	$9K	Hold	1,000	–	–	﹤0.01%	1354
2016 Q1	$7K	Buy	+1,000	New	+$7.3K	﹤0.01%	1408

Other funds holding CYTK

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Geneos Wealth Management's CYTK Position: Q3 2025 in Review

Geneos Wealth Management sold out of Cytokinetics (CYTK) in Q3 2025, closing a stake of 17 shares — an estimated $562 sold.

Geneos Wealth Management first reported a position in CYTK in Q1 2016 and held it in 27 quarters. The position peaked at $38K in Q1 2021. 380 funds tracked by Wall St. Rank hold CYTK as of Q3 2025.

Geneos Wealth Management reported no remaining Cytokinetics position as of Q3 2025 after selling out during the quarter.
Geneos Wealth Management sold 17 Cytokinetics shares in Q3 2025, an estimated $562.
Geneos Wealth Management first reported a position in Cytokinetics in Q1 2016 and held it in 27 quarters.
Geneos Wealth Management's Cytokinetics position peaked at $38K in Q1 2021.
380 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.